Gerresheimer’s innovative products for packaging & drug delivery at CPhI China

CPhI China to take place from 16 to 18 December 2020

At CPhI China, Gerresheimer presents its wide range of primary packaging glass: bottles, vials, ampoules, and cartridges. Syringes and medical devices will be presented, and US type containers and CR closures together with dropper bottles and monolayer COP vials. Photo – Gerresheimer

One of the most important events for pharmaceutical packaging and drug delivery in Asia is CPhI China. It will take place – LIVE – from 16 to 18 December 2020 in the well-known venue SNIEC Shanghai, at booth N5P21. The first pharmaceutical trade fair is to go live again during the global pandemic situation while maintaining strict hygiene measures and health controls. Several major trade fairs have already been successfully held in China under these conditions. Due to Gerresheimer’s strong presence in China, a Gerresheimer team based in China will be on the stand to advise customers and potential customers, it said.

At CPhI China, Gerresheimer presents its high-quality specialty products made of glass and plastic for the international pharma and healthcare industry. Gerresheimer Shuangfeng will present its wide range of primary packaging glass – bottles, vials, ampoules, and cartridges. Syringes and medical devices will be presented in the “Customized Drug Delivery Solutions” and “Gx Biological Solutions” areas. Primary Packaging Plastics will present US type containers and CR closures together with dropper bottles and monolayer COP vials.

Gx RTF Vials – sterilized and ready for filling

The Gx RTF injection vials are made of borosilicate glass type I and meet all current requirements of applicable ISO standards and pharmacopoeias (USP and Ph Eur). They are formed according to cGMP, washed in a clean room, packed in trays or nest and tub, and sterilized. Gerresheimer offers its packaging configurations, but also the well-known Ompi EZ-fill packaging format. This means that the vials are ready for the subsequent process steps in filling.

The advantages are obvious – sterile delivery, a simplified filling and finishing process, the highest quality standards, flexibility through different packaging configurations, and a wide range of filling and sealing technologies. All of these factors together ensure an improvement in overall manufacturing costs throughout the product life cycle.

Gx Elite Vials – high-quality for even more patient safety

Gerresheimer CPhI 2020 III

With the Gx Elite Vials for injection materials made of borosilicate glass (Type I) Gerresheimer presents the result of careful product development over many years. During production, glass-to-glass contacts are avoided, ensuring that the vials are highly break-resistant, have high strength, and are free of cosmetic defects. According to the company, it has a high dimensional accuracy; its delamination resistance protects the drug. Easy handling and various packaging options ensure that Gx Elite Vials can be delivered to various filling lines for seamless use. The result is a reduction in costs while increasing quality, as confirmed by numerous ongoing and completed tests at renowned customers.

Vials for injectables from Shuangfeng in China

Gerresheimer Shuangfeng has been supplying many well-known pharmaceutical companies with vials made of tubular glass for decades. The offer covers 1 ml to 50 ml vials, 1 ml to 30 ml ampoules in different designs, as well as dental and insulin cartridges. A professional laboratory for complete glass analysis and test projects, in which extraction and leaching experiments can also be performed, is also available. The Chinese site Gerresheimer Shuangfeng produces vials, ampoules, cartridges, and other special products in clear and amber.

Gx Biological Solutions – Metal-free syringes or baked-on syringes

Gerresheimer CPhI 2020 II

Biotechnologically produced active ingredients have several special features. Some of them are highly viscous, and in some cases, they tend to interact with silicone oil or, for example, tungsten residues from syringe production. Gerresheimer offers a special metal-free syringe for these applications. Prefillable syringes are required for medications based on biotechnologically produced active substances, where metal contamination is ideally ruled out. With the development of innovative and patented production technology, Gerresheimer has been able to meet this requirement and make a metal-free 1 ml long Luerlock Gx RTF syringe ready for production. They could also be delivered with baked-on siliconization.

Primary packaging plastic for drugs produced in China

csm Gerresheimer CPhI 2020 IV 3c652afd3f

Primary Packaging Plastics will be presenting Triveni US type containers and CR closures that are CDE-registered. They will be manufactured at the new plant in Changzhou, China. Dropper bottles for ophthalmic and monolayer COP vials will also be on display on the Gerresheimer stand.

All containers are supplied with various closure options, for example, with tamper-evident, child-resistant, and senior-friendly, and various integrated or mounted desiccant variants and absorbents. DUMA and Triveni are well-known worldwide Gerresheimer trademarks.

The Gerresheimer plants in Asia, Europe, and America work closely together in a worldwide network. They apply Good Manufacturing Practice (CGMP) consistently and are certified to ISO 9001. Some plants also have ISO Certificate 15378 or are even more comprehensively certified. All Gerresheimer products comply with the respective pharmacopoeias.

The Covid-19 pandemic led to the country-wide lockdown on 25 March 2020. It will be two years tomorrow as I write this. What have we learned in this time? Maybe the meaning of resilience since small companies like us have had to rely on our resources and the forbearance of our employees as we have struggled to produce our trade platforms.

The print and packaging industries have been fortunate, although the commercial printing industry is still to recover. We have learned more about the digital transformation that affects commercial printing and packaging. Ultimately digital will help print grow in a country where we are still far behind in our paper and print consumption and where digital is a leapfrog technology that will only increase the demand for print in the foreseeable future.

Web analytics show that we now have readership in North America and Europe amongst the 90 countries where our five platforms reach. Our traffic which more than doubled in 2020, has at times gone up by another 50% in 2021. And advertising which had fallen to pieces in 2020 and 2021, has started its return since January 2022.

As the economy approaches real growth with unevenness and shortages a given, we are looking forward to the PrintPack India exhibition in Greater Noida. We are again appointed to produce the Show Daily on all five days of the show from 26 to 30 May 2022.

It is the right time to support our high-impact reporting and authoritative and technical information with some of the best correspondents in the industry. Readers can power Packaging South Asia’s balanced industry journalism and help sustain us by subscribing.

– Naresh Khanna

Subscribe Now


Please enter your comment!
Please enter your name here